Uneventful Anterior Migration of Intravitreal Ozurdex Implant in a Patient with
Iris-Sutured Intraocular Lens and Descemet Stripping Automated Endothelial Keratoplasty.
Case Rep Ophthalmol 2018;
9:143-148. [PMID:
29643797 PMCID:
PMC5892334 DOI:
10.1159/000486924]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
Purpose
We report here the case of a patient with anterior segment migration of intravitreal dexamethasone implant as well as its management and outcome.
Methods
The patient had the following sequence of events: complicated cataract surgery, iris-sutured intraocular lens implant, followed by cystoid macular edema treated with intravitreal Avastin, retinal vein occlusion treated with intravitreal dexamethasone implant, corneal decompensation treated with Descemet stripping automated endothelial keratoplasty (DSAEK), and finally recurrence of macular edema treated with repeated intravitreal dexamethasone implant.
Results
Dexamethasone implant had completely dissolved from the eye 12 weeks after insertion without any complication.
Conclusion
A conservative approach with regular monitoring in the situation of a quiet anterior segment without any corneal decompensation can provide enough time for the implant to dissolve without causing any complication to the involved eye, avoiding any additional surgical intervention, as presented in this case report. Despite the fact that the implant was left for natural dissolution, there were no adverse effects related to the graft or the eye.
Collapse